Identification of parameters required for efficient lentiviral vector transduction and engraftment of human cord blood CD34+ NOD/SCID-repopulating cells

Experimental Hematology

Volumn 36, Issue 8, 2008, Pages 947-956

  Liu, Ying ^a   Hangoc, Giao ^a   Campbell, Timothy B ^a   Goodman, Michael ^a   Tao, Wen ^a   Pollok, Karen ^a   Srour, Edward F ^a   Broxmeyer, Hal E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GROWTH FACTOR; LENTIVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL EXPANSION; CELL POPULATION; CONTROLLED STUDY; CULTURE MEDIUM; EX VIVO STUDY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; SCID MOUSE; UMBILICAL CORD BLOOD; VIRAL GENE THERAPY;

ANIMALS; ANTIGENS, CD34; COLONY-FORMING UNITS ASSAY; FETAL BLOOD; GENETIC VECTORS; GRAFT SURVIVAL; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LENTIVIRUS; MICE; MICE, INBRED NOD; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS;

BOVINAE; MUS;

EID: 47149099979     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.06.005     Document Type: Article

References (31)

1. Brenner M.K., and Heslop H.E. Is retroviral gene marking too dangerous to use?. Cytotherapy 5 (2003) 190-193
2. th ed (2008), Blackwell Scientific Publications, Cambridge, MA In press
3. Dando J.S., Aiuti A., Deola S., et al. Optimisation of retroviral supernatant production conditions for the genetic modification of human CD34+ cells. J Gene Med 3 (2001) 219-227
4. Emery D.W., Nishino T., Murata K., et al. Hematopoietic stem cell gene therapy. Int J Hematol 75 (2002) 228-236
5. Gluckman E., Rocha V., Boyer-Chammard A., et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 337 (1997) 373-381
6. Ando K., Yahata T., Sato T., et al. Direct evidence for ex vivo expansion of human hematopoietic stem cells. Blood 107 (2006) 3371-3377
7. Bhatia M., Bonnet D., Kapp U., et al. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 186 (1997) 619-624
8. Piacibello W., Bruno S., Sanavio F., et al. Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient. Blood 100 (2002) 4391-4400
9. Ueda T., Tsuji K., Yoshino H., et al. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest 105 (2000) 1013-1021
10. Dorrell C., Gan O.I., Pereira D.S., et al. Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function. Blood 95 (2000) 102-110
11. Gothot A., van der Loo J.C., Clapp D.W., et al. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood 92 (1998) 2641-2649
12. Rebel V.I., Tanaka M., Lee J.S., et al. One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus. Blood 93 (1999) 2217-2224
13. Miyoshi H., Smith K.A., Mosier D.E., et al. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283 (1999) 682-686
14. Basu S., Ray N.T., Atkinson S.J., et al. Protein phosphatase 2A plays an important role in stromal cell-derived factor-1/CXC chemokine ligand 12-mediated migration and adhesion of CD34+ cells. J Immunol 179 (2007) 3075-3085
15. Ishikawa F., Yasukawa M., Lyons B., et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 106 (2005) 1565-1573
16. Ito M., Hiramatsu H., Kobayashi K., et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100 (2002) 3175-3182
17. Zack J.A., Haislip A.M., Krogstad P., et al. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J Virol 66 (1992) 1717-1725
18. Mazurier F., Gan O.I., McKenzie J.L., et al. Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment. Blood 103 (2004) 545-552
19. McKenzie J.L., Gan O.I., Doedens M., et al. Reversible cell surface expression of CD38 on CD34-positive human hematopoietic repopulating cells. Exp Hematol 35 (2007) 1429-1436
20. Lee C.I., Kohn D.B., Ekert J.E., et al. Morphological analysis and lentiviral transduction of fetal monkey bone marrow-derived mesenchymal stem cells. Mol Ther 9 (2004) 112-123
21. Nayak S.K., McCallister T., Han L.J., et al. Transduction of human renal carcinoma cells with human gamma-interferon gene via retroviral vector. Cancer Gene Ther 3 (1996) 143-150
22. Takatoku M., Sellers S., Agricola B.A., et al. Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates. J Clin Invest 108 (2001) 447-455
23. Reiser J., Harmison G., Kluepfel-Stahl S., et al. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci U S A 93 (1996) 15266-15271
24. Spina C.A., Guatelli J.C., and Richman D.D. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. J Virol 69 (1995) 2977-2988
25. Zack J.A., Arrigo S.J., Weitsman S.R., et al. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61 (1990) 213-222
26. Cui Y., Golob J., Kelleher E., et al. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells. Blood 99 (2002) 399-408
27. Evans J.T., Cravens P., Gatlin J., et al. Pre-clinical evaluation of an in vitro selection protocol for the enrichment of transduced CD34+ cell-derived human dendritic cells. Gene Ther 8 (2001) 1427-1435
28. Woods N.B., Fahlman C., Mikkola H., et al. Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells. Blood 96 (2000) 3725-3733
29. Zhang S., Joseph G., Pollok K., et al. G2 cell cycle arrest and cyclophilin A in lentiviral gene transfer. Mol Ther 14 (2006) 546-554
30. Di Nunzio F., Piovani B., Cosset F.L., et al. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein. Hum Gene Ther 18 (2007) 811-820
31. Qiao J., Moreno J., Sanchez-Perez L., et al. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment. Gene Ther 13 (2006) 1457-1470